Synthesis and Biological Evaluation of Novel Thiadiazole Derivatives as Antiplatelet Agents
| Author | Mahsima Khakpash | en |
| Author | Marjan Esfahanizadeh | en |
| Author | Mohammad Mahboubi-Rabbani | en |
| Author | Salimeh Amidi | en |
| Author | Farzad Kobarfard | en |
| Orcid | Salimeh Amidi [0000-0002-6032-3237] | en |
| Orcid | Farzad Kobarfard [0000-0001-6679-3275] | en |
| Issued Date | 2023-12-31 | en |
| Abstract | A novel series of thiadiazole compounds was synthesized through the reaction of thiosemicarbazone intermediates with 2, 3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ). The antiplatelet activity of the synthesized compounds was evaluated using an aggregation test with adenosine diphosphate (ADP) and arachidonic acid (AA) as platelet aggregation inducers. Among the synthesized analogs, compound 3b exhibited the most potent inhibition of platelet aggregation induced by ADP (half maximal inhibitory concentration [IC50] = 39 ± 11 µM). Molecular docking studies of 3b revealed hydrogen bonds between the nitrogen of the thiadiazole ring and Lys280. The tolyl ring exhibited hydrophobic interactions with Tyr105, similar to the antagonist co-crystallized with P2Y12 (PDB ID: 4NTJ). These compounds have the potential to serve as lead molecules for designing P2Y12 inhibitors. | en |
| DOI | https://doi.org/10.5812/ijpr-141846 | en |
| Keyword | Thiadiazole | en |
| Keyword | Antiplatelet | en |
| Keyword | Arachidonic Acid (AA) | en |
| Keyword | Adenosine Diphosphate (ADP) | en |
| Keyword | Cyclization | en |
| Keyword | P<sub>2</sub>Y<sub>12</sub> Inhibitors | en |
| Publisher | Brieflands | en |
| Title | Synthesis and Biological Evaluation of Novel Thiadiazole Derivatives as Antiplatelet Agents | en |
| Type | Research Article | en |